Page 5 - Evofem Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Equities analysts predict that Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Rating) will report sales of $6.65 million for the current fiscal quarter, Zacks reports. Three analysts have made estimates for Evofem Biosciences’ earnings. The lowest sales estimate is $5.50 million and the highest is $8.56 million. Evofem Biosciences reported sales of $1.86 million in the […]

/PRNewswire/ -- Evofem Biosciences, Inc. (Nasdaq: EVFM) (Evofem) today announced that the U.S. Food and Drug Administration (FDA) has formally extended the...

/PRNewswire/ -- Evofem Biosciences, Inc. (Nasdaq: EVFM) (Evofem) today announced the pricing of its previously announced underwritten public offering of...

/PRNewswire/ -- Evofem Biosciences, Inc. (Nasdaq: EVFM) (Evofem) today announced that it intends to offer and sell shares of its common stock (or pre-funded...

/PRNewswire/ -- Evofem Biosciences, Inc. (Nasdaq: EVFM) (Evofem) today announced that it intends to offer and sell shares of its common stock (or pre-funded...